Petrus Trust Company’s 10x Genomics TXG Stock Holding History

Petrus Trust Company’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-27,157	Closed	-$314K	–	519
2025 Q2	$314K	Buy	+27,157	New	+$248K	0.03%	298
2024 Q3	–	Sell	-14,621	Closed	-$284K	–	751
2024 Q2	$284K	Buy	14,621 +4,274	+41%	+$112K	0.03%	454
2024 Q1	$388K	Buy	+10,347	New	+$455K	0.04%	324
2022 Q1	–	Sell	-1,397	Closed	-$208K	–	156
2021 Q4	$208K	Buy	+1,397	New	+$214K	0.02%	102

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Petrus Trust Company's TXG Position: Q3 2025 in Review

Petrus Trust Company sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 27,157 shares — an estimated $314K sold.

Petrus Trust Company first reported a position in TXG in Q4 2021 and held it in 4 quarters. The position peaked at $388K in Q1 2024. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

Petrus Trust Company reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
Petrus Trust Company sold 27,157 10x Genomics shares in Q3 2025, an estimated $314K.
Petrus Trust Company first reported a position in 10x Genomics in Q4 2021 and held it in 4 quarters.
Petrus Trust Company's 10x Genomics position peaked at $388K in Q1 2024.
317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.